# Phase III Randomized Trial of Adjuvant Chemotherapy With S-1 vs S-1/Oxaliplatin ± Radiotherapy for Completely Resected Gastric Adenocarcinoma : The ARTIST II Trial

> **NCT01761461** · PHASE3 · UNKNOWN · sponsor: **Samsung Medical Center** · enrollment: 547 (actual)

## Conditions studied

- Gastric Cancer

## Interventions

- **DRUG:** TS-1, oxaliplatin

## Key facts

- **NCT ID:** NCT01761461
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-02-06
- **Primary completion:** 2020-12
- **Final completion:** 2020-12
- **Target enrollment:** 547 (ACTUAL)
- **Last updated:** 2020-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01761461

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01761461, "Phase III Randomized Trial of Adjuvant Chemotherapy With S-1 vs S-1/Oxaliplatin ± Radiotherapy for Completely Resected Gastric Adenocarcinoma : The ARTIST II Trial". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01761461. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*